Houston, TX - June 11th, 2025 - OmniScience, the AI company behind Vivo, the first agentic AI control tower for clinical trials, announced today its acceptance into the Google for Startups Cloud Program. This global program provides technical enablement, cloud credits, and direct access to Google’s network of experts and partners to high-potential startups.

The program supports OmniScience’s mission to transform clinical trial operations with intelligent automation, real-time decision support, and explainable AI. Through this partnership, OmniScience will gain access to exclusive resources including advanced cloud infrastructure, AI tooling, and strategic advisory support from Google’s startup team.

“This is a meaningful milestone for OmniScience as we continue to scale Vivo’s impact across life sciences,” said Colin Hendricks, CTO of OmniScience. “Being part of the Google for Startups Cloud Program helps us move faster, build smarter, and bring powerful genAI capabilities to clinical development teams globally.”

Vivo is designed to unify fragmented clinical trial data, reduce operational burden, and equip trial teams with on-demand insights, proactive risk detection, and regulatory-grade auditability. With Google Cloud’s scalable infrastructure and machine learning stack, OmniScience is positioned to deliver even greater value to clients navigating complex, data-intensive trials.